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Objective: The preconception period is largely neglected, whereas it represents an opportunity to identify 
and modify clinical and behavioral risks, particularly in infertile women characterized by an unfavorable 
vascular burden. The present study was performed to strengthen previous findings and to increase the 
awareness of clinicians who should envision a broader preconception approach in infertile women, 
beyond their reproductive health.  
Materials and methods: In this cross-sectional study, we investigated 1003 Caucasian women, referred 
to the Internal Medicine Clinic at the Assisted Reproductive Technologies Center, Florence. 
Results: A high prevalence of dyslipidemia (57.4%), overweight/obesity (29.1%) and, smoking habit 
(26.6%) were found. We provided evidence of unhealthy lifestyle habits, represented by a closer 
adherence to the Mediterranean diet in the 9.5% only and by a sedentary behavior in 73%. A significant 
correlation between the Mediterranean Diet score and both anthropometric and metabolic parameters 
was found. We also observed a lower score adherence with both metabolic syndrome and diabetes (for 
both p=0.02), but not with hypertension. 
Conclusion: Before infertility treatment, the correction and the management of modifiable and  
non-modifiable cardiovascular risk factors are mandatory and represent the main goal for a safe 
pregnancy, and lifetime women’s health. 
 





The preconception period represents an opportunity 
to identify and modify clinical and behavioral risks in 
women undergoing Assisted Reproductive 
Technology (ART), to prevent cardiovascular 
disorders (1). Maternal clinical assessment should be 
planned before beginning infertility treatment, 
                                                 
Correspondence: 
Dr. Cinzia Fatini 
Email: cinzia.fatini@unifi.it 
through interventions aimed to obtain successful 
pregnancy outcomes and a healthy child (1). The 
period around conception is aimed to optimize 
gamete function and early placental development, to 
decrease the risk of pre-eclampsia, miscarriage, low 
birth weight, small for gestational age, stillbirth and 
neonatal death (2). 
Older maternal age at the time of pregnancy, and 
the presence of comorbidities, such as obesity, in 
particular visceral obesity, dyslipidemia, 
hypertension, diabetes and metabolic syndrome, may 
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affect cardiovascular women’s health, and contribute 
to excessive rates of maternal short and long-term 
morbidity.  
To date, fertility therapy in women undergoing 
ART, may act as a cardiometabolic stress by increasing 
risk of long-term adverse cardiovascular events 
following unsuccessful treatment (3). Fertility therapy 
failure may represent a sex specific cardiovascular risk 
factor useful to identify women who may benefit from a 
cardiovascular risk evaluation (3). 
Diet and nutrition before pregnancy may affect 
maternal and perinatal outcomes by influencing Body 
Mass Index (BMI) or nutritional factors. Among 
dietary patterns, greater adherence to the 
Mediterranean diet seems to be associated with 
increased chances of a successful pregnancy for 
women undergoing ART (4), and reduced risk of 
pregnancy complications (5, 6). It has also been 
demonstrated that increased physical activity before 
pregnancy was associated with a reduction in the risk 
of negative pregnancy outcomes (7, 8).  
The implementation of the preconception 
healthcare in natural pregnancy contributes to 
improving maternal outcomes (9) and fetal offspring 
(10), but the evidence about its role in women 
undergoing ART are few (11, 12). 
The preconception period is largely neglected, 
whereas efforts to improve preconception health 
should be aimed at all women, in particular those 
planning ART, characterized by an unfavorable 
vascular burden, as previously documented (13).  
In our study published in 2018, we reported 
preliminary data about the experience of the Internal 
Medicine Clinic at the Assisted Reproductive 
Technologies Cente, Florence. After two years, we 
extended the present study to a larger sample to 
estimate if the prevalence of comorbidities in infertile 
women previously observed, was fully representative 
of the “real world” or was biased by the small 
number of women enrolled.  
The present study was performed in order not only 
to strengthen our previous results but also to increase 
the awareness of clinicians who should envision a 
broader preconception approach in infertile women 
undergoing ART, beyond their reproductive health.  
Materials and methods 
This cross-sectional study represented an update two 
years later of our previous study (13), from 
November 2017 to September 2019, performed on 
Caucasian women at the Internal Medicine Clinic, at 
the Assisted Reproductive Technologies Center, 
Division of Obstetrics and Gynecology, University 
Hospital, Careggi, Florence, Italy. The Internal 
Medicine Clinic consists of a multidisciplinary team 
of Internal Medicine and Nutrition experts, 
specifically focussed on the prevention of 
cardiovascular risk in women.  
After performing infertility evaluation, 
gynecologists referred women with age more than 40 
yrs and/or comorbidities, as well as a history of 
recurrent unexplained pregnancy loss and/or 
implantation failure to Internal Medicine Clinic 
before attempting ART. Information concerning 
cardiometabolic parameters derived from clinical 
reports and cardiovascular risk factors were 
investigated during the clinical evaluation. The entire 
study population comprised 1003 Caucasian women 
[median age 40 yrs, (range 25-49)]. 
According to the World Health Organization 
criteria, underweight was defined as BMI values 
<18.5 and overweight was defined as BMI values 25-
29.99 Kg/m2, first grade obesity as BMI values 30-
34.99 Kg/m2, second grade obesity as BMI 35-39.99 
Kg/m2, and third grade obesity as BMI ≥40 Kg/m2.  
All anthropometric parameters were also 
measured; waist circumference was measured 
midway between the inferior margin of the lowest rib 
and the iliac crest in the horizontal plane at the end of 
normal expiration; hip circumference was measured 
at the widest point over the buttocks. The 
anthropometric measures were performed by the 
same operator. A value of ≥80 cm was considered a 
marker of increased cardiovascular risk according to 
Alberti KG. et al. (14); waist to hip ratio (WHR) was 
obtained by dividing the waist circumference by hip 
circumference, and a value >0.80 was considered a 
marker of increased cardiovascular risk (15). 
Dyslipidemia was defined according to the European 
Society of Cardiology (ESC) guidelines (16). 
The women were considered to have hypertension 
if they had been diagnosed as hypertensives 
according to ESH/ESC guidelines (≥140/90 mmHg) 
or were taking antihypertensive drugs (17). Diabetes 
was defined in agreement with the American 
Diabetes Association (18); smokers were defined as 
current or recent (ex-smokers who stopped less than 5 
years earlier) smokers. Metabolic Syndrome was 
defined according to the International Diabetes 
Federation (14). Diagnosis of migraine with aura had 
been performed by physicians according to the 
International Classification of Headache Disorders 
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3rd edition (19).  
To better define cardiovascular risk profile, and 
based on the evidence linking preconception health, 
in particular nutritional status, to pregnancy and birth 
outcomes, information concerning physical activity 
and habitual food intake were added.  
Physical activity grade was investigated and 
sedentary behavior was defined as absent or light (ie, 
either occasional walking or recreational activity 
only). Moreover, a validated 14-items Mediterranean 
Diet Assessment Tool was administered. The 
PREDIMED (Primary Prevention of Cardiovascular 
Disease with a Mediterranean Diet) score represents 
the primary measure used in the PREDIMED trial 
(randomized, cardiovascular primary prevention trial) 
to appraise adherence of participants to the 
Mediterranean Diet. PREDIMED score consists of 
14-items, which evaluated Mediterranean typically 
dietary pattern, based on foods such as vegetables, 
fruits, whole or minimally processed foods, fish, 
legumes, vegetable fat from olive oil and adverse 
dietary factors such as sugar-sweetened beverage, red 
and processed meat. Three categories of adherence to 
Mediterranean diet (≤ 5 low, 6-9 moderate, ≥10 high 
adherence points of the 14-item questionnaire) (20) 
were considered.  
Informed written consent for anonymous data 
analysis was obtained from all women. The 
investigation conforms to the principles outlined in 
the Declaration of Helsinki. The original study was 
approved at the local Ethics Committee (Azienda 
Ospedaliera Universitaria Careggi, prot. 34044, 
11292/OSS). 
Statistical analysis: Statistical analysis was 
performed by using the SPSS (Statistical Package for 
Social Sciences, Chicago, USA) software for 
Windows (Version 25.0). Continuous variables were 
expressed as median and range. Correlation analysis 
was measured by using Pearson's correlation test. A 
p-value <0.05 was considered to indicate statistical 
significance. The categorical variables were 
expressed as frequencies and percentages. 
We calculated sample size referring to our 
previous study (13); sample size calculation indicated 
that at least 242 subjects were sufficient to detect, 
with a statistical power of 70% (β) and a significance 
value of 0.05 (α). 
Results 
In Table 1 we reported demographical and clinical 
characteristics of the study population. 
Table 1: Clinical characteristics of study population 
Variables n = 1003 
Age, years 40 (25-49)* 
Age > 40 years 484 (48.3) 
BMI <18.5 Kg/m2 43 (4.3) 
BMI 25-29.99 Kg/m2 211 (21) 
BMI 30-34.99 Kg/ m2 66 (6.6) 
BMI 35-39.99 Kg/ m2 12 (1.2) 
BMI ≥40 Kg/ m2 3 (0.3) 
WAIST circumference, cm 87 (64-126)* 
WAIST circumference ≥80 cm 631 (62.9) 
WHR 0.81 (0.7-1.0)* 
WHR > 0.80 530 (52.8) 
Smoking habit (current) 267 (26.6) 
Dyslipidemia 576 (57.4) 
Hypertension 41 (4.1) 
Diabetes 23 (2.3) 
MetS 37 (3.7) 
Sedentary behaviour 732 (73) 
POI 84 (8.4) 
Migraine with aura 51 (5.1) 
Recurrent spontaneous miscarriage ≥2 153 (15.3) 
Recurrent ART failure ≥2 348 (34.7) 
Celiac disease 7 (0.7) 
Hashimoto's thyroiditis 48 (4.8) 
Personal history of  atherothrombotic disease 37 (3.7) 
Family history of CV disease, n (%)  277 (27.6) 
*Median (Range) Values are reported as median (range) or n (%).  
BMI: Body Mass Index; WHR: Waist to hip ratio; MetS: Metabolic 
Syndrome; POI: Premature ovary insufficiency; ART: Assisted 
Reproductive Techology; CV: Cardiovascular 
 
The evaluation of traditional cardiovascular risk 
factors evidenced a high prevalence of dyslipidemia 
(57.4%), smoking habit (26.6%), and 
overweight/obesity (29.1%). The evaluation of 
anthropometric measures, such as waist 
circumference and WHR, showed that values of waist 
circumference ≥80 cm, a measure of visceral 
adiposity, were present in 62.9% and WHR value 
>0.80 was also present in 52.8% of women 
investigated. In framing women risk profile we also 
considered personal and family history of 
cardiovascular disease, and we observed that 27.6% 
of ART women had a family history of 
cardiovascular disease, and 3.7% had a personal 
history of premature atherothrombotic disease (i.e. 
acute coronary syndrome or transient ischemic attack 
and venous thrombosis). As concerns migraine with 
aura, hypertension, and diabetes, which are known as 
stronger and more prevalent risks factor in women, 
we observed a prevalence of 5.1%, 4.1%, and 2.3% 
respectively. The metabolic syndrome, a cluster of 
cardiovascular risk factors, was present in 3.7%. 
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By analyzing personal negative obstetric history, a 
sex-specific cardiovascular risk factor, we found that 
15.3% women had a recurrent spontaneous 
miscarriage (≥2), and 34.7% two or more ART 
failures (Table 1). 
Table 2 reported humoral parameters of women 
planning ART. Based on the high prevalence of 
dyslipidemia in our study population, we analyzed 
each parameter of lipid metabolism to better frame 
the vascular risk profile in women planning Assisted 
Reproduction.  We found a high percentage of 
women with both LDL cholesterol >115 mg/dL 
(43.2%), and low HDL cholesterol (<48 mg/dL) 
(13.5%); moreover, elevated concentration of 
Lipoprotein (a) was present in 25.6% of women 
investigated, thus confirming an unfavourable lipid 
profile after extending sample size.  
 
Table 2: Biohumoral parameters of study population 
Variables n = 1003 
Total cholesterol > 200 mg/dL 368 (36.7) 
HDL-c < 48 mg/dL 135 (13.5) 
LDL-c > 115 mg/dL 433 (43.2) 
Tryglicerides > 150mg/dL 71 (7.1) 
Lipoprotein (a) > 300 mg/L 257 (25.6) 
Homocysteine > 13 µmol/L 105 (10.5) 
Vitamin B6 µg/L 10.7 (2.7-44.6)* 
Vitamin B6 <3.6 µg/L 21 (2.1) 
Vitamin B12 pg/mL 346 (34-1684)* 
Vitamin B12 <254 pg/mL 219 (21.8) 
Folic Acid ng/mL 7.5 (1.5-62.1)* 
Folic Acid <3.1 ng/mL 38 (3.8) 
Creatinine mg/dL 0.7 (0.3-2)* 
Fasting glucose mg/dL 87 (61-156)* 
Fasting glucose ≥100 mg/dL 87 (8.7) 
HbA1C mmol/mol 34 (22-52)* 
HbA1C ≥38 mmol/mol 120 (12) 
HOMA index 1.4 (0.2-27.1)* 
hs-CRP mg/L 1.6 (0.1-33.2)* 
TSH mIU/L 1.8 (0.1-6.6)* 
Factor V Leiden heterozigotes 56 (5.6) 
Prothrombin G20210A  
mutation heterozigotes 
58 (5.8) 
PC, PS, AT deficiency 36 (3.6) 
Positivity for at least one of 
antiphospholipid antibodies, n (%) 
89 (8.9) 
*Median (Range) 
HbA1C: Glycated hemoglobin; HOMA: Homeostatic model assessment; 
hs-CRP: High sensitive C Reactive Protein; TSH: Thyroid stimulating 
hormone; PC: Protein C; PS: Protein S; AT: Antitrombin 
 
Data from thrombophilia, demonstrated a similar 
percentage of inherited parameters, as observed in 
our previous study (13), whereas an increased 
positivity of at least one antiphospholipid antibodies 
was observed (Table 2).   
Physical activity and Nutrition: To estimate 
habitual food intake, we used PREDIMED score. In 
Fig.1 (a,b) data concerning the adherence to the 
Mediterranean diet are reported. Only 9.5% of 
women showed a closer adherence to the 
Mediterranean diet corresponding to levels of 
adherence of ≥10 points in the 14-item score.  
 
Figure 1: PREDIMED score consists of 14-items which 
evaluated Mediterraean typically dietary pattern. Three 
categories of adherence to Mediterranean diet ≤5, 6-9, 
≥10 points were considered. Values are expressed as 
percentage (a), Distribution of percentage of adherence 
to Mediterranean diet, according to achieved score (b). 
 
A significant correlation between the 
Mediterranean diet score and both anthropometric 
and metabolic parameters was found (Table 3). By 
evaluating the relationship between metabolic 
syndrome and diabetes to categories of adherence to 
the Mediterranean diet (≤5 low, 6-9 moderate, ≥10 
high adherence points), we observed that a lower 
score adherence was associated with both metabolic 
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with hypertension and smoking habit. 
 
Table 3: Correlation between anthropometric, 
biohumoral parameters and 14-item Mediterranean 
diet assessment tool 
 14-item Mediterranean 
diet assessment tool 
r p 
BMI -0.53 < 0.0001 
WAIST circumference WHR -0.47 < 0.0001 
WHR -0.37 0.01 
Total cholesterol -0.13  0.07 
HDL-c 0.39 < 0.0001 
LDL-c -0.24 0.01 
Triglycerides -0.29 < 0.0001 
Fasting glucose  -0.22 0.004 
HbA1C -0.18 0.04 
HOMA index -0.30 0.001 
BMI: Body Mass Index; WHR: Waist to hip ratio; HbA1C: Glycated 
hemoglobin; HOMA: Homeostatic model assessment 
 
Moreover, we investigated physical activity grade, 
and sedentary behaviour was observed in 73% of women. 
Discussion  
Findings from the present study confirm, in a larger 
sample, that women undergoing ART show an 
unfavorable vascular burden. 
In the preconception period, it should be strongly 
advised to modify lifestyle habit, and to mitigate the 
effect of cardiometabolic disorders, which may 
impact women's cardiovascular health and 
reproductive outcomes. ART care represents a unique 
opportunity for preconception counseling, since the 
moment of conception is easily recognizable (1). 
Nevertheless, the significance of preconception 
care in infertile couples is still an undervalued area of 
clinical practice. 
Notably, additional data from the present study 
provided evidence of an unhealthy lifestyle, in 
particular, a closer adherence to a the Mediterranean 
diet was present only in about 9.5%, and sedentary 
behavior in more than 70% of women.  
Cardiovascular disease is a global health concern 
amenable to behavior modifications. Diet is a vital 
lifestyle component that affects cardiovascular risk 
through body weight and many other pathways (21). 
It is well known that greater adherence to the 
Mediterranean diet is linked to a reduced risk of 
overall mortality, cardiovascular diseases, overall 
cancer incidence, neurodegenerative diseases, and 
diabetes (22). Our findings evidenced an inverse 
association between adherence to Mediterranean Diet 
and cardiovascular risk markers related to glucose 
metabolism, adiposity, and lipids. These results, 
referring to preconception period, support previously 
reported benefits of the Mediterranean diet for 
cardiovascular risk reduction (23). 
Moreover, a greater degree of protection may occur 
in particular when lifestyle factors are adopted before 
and throughout pregnancy. Recent data are suggesting 
that the Mediterranean Diet, rich in fruit and vegetables, 
whole grains, legumes, extra virgin olive oil, fish and 
low intake of red and processed meat, seems to be 
associated with increased chances of a successful 
pregnancy in women undergoing ART (4). 
Nevertheless, the benefits of a healthy diet in improving 
ART pregnancy outcomes, remain unclear (24).  
Despite in several Italian Center dietary 
counseling is not routine before ART, our approach 
was different, aiming at identifying women at risk of 
less adherence to this dietary pattern as essential in 
implementing effective strategies to promote the 
health benefits of this dietary model. The other side 
of the matter is the adoption of physical activity in 
women planning a pregnancy, a promising 
intervention in the prevention of Gestational Diabetes 
Mellitus and pre-eclampsia (7, 8). This evidence 
underlines the opportunity to perform further 
interventions, in particular during the preconception 
period to ensure the best outcomes throughout 
pregnancy (7). There is however, a need for 
prospective studies to better understand the 
mechanisms by which physical activity and diet 
affect obstetric outcomes and maternal health.  
In the present study, a poor pre-pregnancy 
cardiovascular health was found; in particular, about 
60% of women had dyslipidemia, and about 30% 
were overweight/obese. This altered metabolic profile 
may further worsen if we considered anthropometric 
parameter values, such as waist circumference and 
WHR. In more than 50% of women, we observed 
both waist circumference value ≥80 cm and altered 
WHR.  These findings suggest that medical advice 
prevention and treatment for preconception 
cardiovascular risk factors are needed and might 
contribute to control the added risk of ART; namely, 
we need to plan strategies and interventions aimed to 
change modifiable cardiovascular risk factors, thus 
improving health behaviors.   
Data from literature evidenced that history of 
pregnancy complications determines an increased 
future cardiovascular risk (25, 26); because of its 
unique cardiovascular and metabolic stress, 
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pregnancy permits to estimate a woman’s lifetime 
risk. Women who failed this stress test by 
experiencing placental disorders have an increased 
future cardiovascular risk, possibly unmasking early 
or pre-existing endothelial dysfunction and vascular 
disease (27); to date, a history of pregnancy 
complications as a major risk factor for 
cardiovascular disease in the AHA/ASA guidelines 
(28, 29). It is noteworthy that pregnancy transiently 
catapults a “healthy” woman into an altered 
metabolic status that predisposes to vascular 
endothelial dysfunction (30). Women already prone 
to this phenotype, and in particular, women 
undergoing ART, often develop gestational 
hypertension or diabetes mellitus, which re-emerge in 
later life as the metabolic syndrome returns (30).  
Furthermore, women undergoing ART had a higher 
incidence of hypertension, and a trend toward a higher 
incidence of stroke, thus in turn a higher propensity to 
develop cardiovascular disease later in life (31). 
Therefore, there is a need to investigate the impact of 
ART on cardiovascular health, as reported by Becerra-
Gonzales 2020 (32). This topic is timely in an era 
where more women are undergoing ART at a later age 
and reccomendations for cardiovascular health and 
future consequences are not well known (33). This 
study has several strengths. It was based on a large 
sample, permitting to confirm previous findings (13), 
which evidenced a high prevalence of cardiometabolic 
risk factors in ART women, in particular dyslipidemia 
and overweight/obesity. The amount of collected data 
from participants was considered appropriate to make 
assumptions on future possible therapeutical 
approaches. Moreover, a full set of laboratory tests, 
along with a validated questionnaire, had been 
administered to all participants.  
The current research represents a comprehensive 
analysis of multiple domains of preconception health, 
thus adding, with special regards, accurate and detail 
information on cardiovascular profile in women 
planning ART.  
Many earlier published reports provide 
recommendations to improve preconception health care. 
It is well known that the implementation of the 
interventions preceding natural pregnancy to detect, treat, 
and help women modifying behaviors and risk factors, 
may contribute to improving maternal outcomes (9). 
Nevertheless, the evidence about the role of 
preconception care in women undergoing ART are 
few (11) A low number of studies report all the 
domains of preconception health in women 
undergoing ART, in particular in older women, who 
are at higher risk of adverse obstetric outcomes and 
cardiovascular diseases later in life (31). A recent 
review underlines that special attention must be paid 
to the workup of certain patient populations, such as 
those with age older than 35 years, comorbidities 
(especially hypertension, diabetes, and 
thrombophilias), and obesity (33). In keeping with 
our findings, the authors promote the need of patient-
centered counseling before the initiation of ART. 
On the other hand, our study has some potential 
limitations. One is represented by the cross-sectional 
nature of the research itself; besides that, the study 
does not include information regarding vascular and 
obstetric clinical outcomes after ART. Moreover, all 
participants were Caucasians, and thus findings may 
not be generalizable to other racial and ethnic groups. 
Conclusion 
Findings from the present study strengthen our 
previous results in a larger sample of ART women. 
Beyond reproductive health, clinicians should increase 
their awareness, envisioning a broader preconception 
approach in women undergoing ART. Our data 
highlight the complex clinical picture of ART women 
and underline the need for a multidisciplinary team 
consisting of gynecologists, who have a key role, and 
clinicians expert in women’s healthcare. 
Despite the widespread application of ART, the 
body of knowledge to preconception care in 
pregnancy after ART is limited.  
During the preconception period, all women 
should be screened to determine their cardiovascular 
risk profile and to treat comorbidities before and 
during infertility treatment.  
Further studies to improve the knowledge and 
behaviors of preconception health in women planning 
ART will be required.  
Finally, before infertility treatment, the correction 
and/or the management of modifiable and non-
modifiable cardiovascular risk factors are mandatory 
and represent the main clinical goal for both a safe 
pregnancy and lifetime women’s health. 
 
Conflict of Interests 
Authors have no conflict of interests. 
Acknowledgments 
Authors have no conflict of interests in this paper. 
Cirillo et al. 
156      Vol. 14, No. 3, September 2020 http://jfrh.tums.ac.ir Journal of Family and Reproductive Health  
References 
1. WHO Policy Brief. Preconception care: Maximizing 
the gains for maternal and child health. 2013:1–8.  
2. Stephenson J, Heslehurst N, Hall J, et al. Before the 
beginning: nutrition and lifestyle in the preconception 
period and its importance for future health [published 
correction appears in Lancet. 2018;391:1830-41. 
3. Udell JA, Lu H, Redelmeier DA. Failure of fertility 
therapy and subsequent adverse cardiovascular events. 
CMAJ. 2017; 189:E391-7. 
4. Karayiannis D, Kontogianni MD, Mendorou C, 
Mastrominas M, Yiannakouris N. Adherence to the 
Mediterranean diet and IVF success rate among non-obese 
women attempting fertility. Hum Reprod. 2018;33:494-502. 
5. Assaf-Balut C, García de la Torre N, Durán A, et al. A 
Mediterranean diet with additional extra virgin olive oil 
and pistachios reduces the incidence of gestational 
diabetes mellitus (GDM): A randomized controlled 
trial: The St. Carlos GDM prevention study. PLoS One. 
2017;12:e0185873 
6. Parlapani E, Agakidis C, Karagiozoglou-Lampoudi T, 
et al. The Mediterranean diet adherence by pregnant 
women delivering prematurely: association with size at 
birth and complications of prematurity. J Matern Fetal 
Neonatal Med. 2019;32:1084-91. 
7. Mijatovic-Vukas J, Capling L, Cheng S, et al. 
Associations of Diet and Physical Activity with Risk 
for Gestational Diabetes Mellitus: A Systematic 
Review and Meta-Analysis. Nutrients. 2018;10:698. 
8. Aune D, Saugstad OD, Henriksen T, Tonstad S. 
Physical activity and the risk of preeclampsia: a 
systematic review and meta-analysis. Epidemiology. 
2014;25:331-43. 
9. Frayne DJ, Verbiest S, Chelmow D, et al. Health Care 
System Measures to Advance Preconception Wellness: 
Consensus Recommendations of the Clinical Workgroup 
of the National Preconception Health and Health Care 
Initiative. Obstet Gynecol. 2016;127:863–72. 
10. Agarwal P, Morriseau TS, Kereliuk SM, Doucette CA, 
Wicklow BA, Dolinsky VW. Maternal obesity, diabetes 
during pregnancy and epigenetic mechanisms that 
influence the developmental origins of cardiometabolic 
disease in the offspring. Crit Rev Clin Lab Sci. 
2018;55:71-101. 
11. Grainger DA, Frazier LM, Rowland CA. Preconception 
care and treatment with assisted reproductive 
technologies. Matern Child Health J. 2006;10:S161-4.  
12. Pothineni NV, Kovelamudi S, Kantipudi S. Assisted 
Reproductive Techniques and Cardiovascular Risk. J 
Am Coll Cardiol. 2019;73:117-8.  
13. Fatini C, Cirillo M, Coccia ME. Assisted Reproductive 
Technology, Comorbidities, and Cardiovascular Risk: 
The Experience of an Italian Center. J Womens Health 
(Larchmt). 2018;27:1285-92. 
14. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task 
Force Consensus Group. The metabolic syndrome--a 
new worldwide definition. Lancet.. 2005; 366:1059-62. 
15. Lear SA, James PT, Ko GT et al. Appropriateness of 
waist circumference and waist-to-hip ratio cutoffs for 
different ethnic groups. Eur J Clin Nutr. 2010; 64:42-61. 
16. European Association for Cardiovascular Prevention & 
Rehabilitation, Reiner Z, Catapano AL, et al. ESC/EAS 
Guidelines for the management of dyslipidaemias: the 
Task Force for the management of dyslipidaemias of 
the European Society of Cardiology (ESC) and the 
European Atherosclerosis Society (EAS). Eur Heart J. 
2011;32:1769-1818. 
17. Mancia G, Fagard R, Narkiewicz K, et al. 2013 
ESH/ESC Guidelines for the management of arterial 
hypertension: the Task Force for the management of 
arterial hypertension of the European Society of 
Hypertension (ESH) and of the European Society of 
Cardiology (ESC). J Hypertens. 2013;31:1281-1357. 
18. Expert Committee on the Diagnosis and Classification 
of Diabetes Mellitus. Report of the expert committee on 
the diagnosis and classification of diabetes mellitus. 
Diabetes Care. 2003;26:S5-20. 
19. Headache Classification Committee of the International 
Headache Society (IHS). The International 
Classification of Headache Disorders, 3rd edition (beta 
version). Cephalalgia. 2013;33:629-808. 
20. Martínez-González MA, García-Arellano A, Toledo E, 
et al. A 14-item Mediterranean diet assessment tool and 
obesity indexes among high-risk subjects: the 
PREDIMED trial. PLoS One. 2012;7:e43134. 
21. Yu E, Malik VS, Hu FB. Cardiovascular Disease 
Prevention by Diet Modification: JACC Health 
Promotion Series. J Am Coll Cardiol. 2018;72:914-26. 
22. Dinu M, Pagliai G, Casini A, Sofi F. Mediterranean 
diet and multiple health outcomes: an umbrella review 
of meta-analyses of observational studies and 
randomised trials. Eur J Clin Nutr. 2018;72:30-43. 
23. Martínez-González MÁ, Hershey MS, Zazpe I, 
Trichopoulou A. Transferability of the Mediterranean 
Diet to Non-Mediterranean Countries. What Is and What 
Is Not the Mediterranean Diet Nutrients. 2017;9:1226. 
24. Ricci E, Bravi F, Noli S, et al. Mediterranean diet and 
outcomes of assisted reproduction: an Italian cohort 
study. Am J Obstet Gynecol. 2019;221:627. 
25. Smith GC, Pell JP, Walsh D. Pregnancy complications 
and maternal risk of ischaemic heart disease: a 
retrospective cohort study of 129,290 births. Lancet. 
Preconception Health in Assisted Reproduction 
 Journal of Family and Reproductive Health http://jfrh.tums.ac.ir Vol. 14, No. 3, September 2020      157 
2001;357:2002‐6. 
26. Berends AL, de Groot CJ, Sijbrands EJ, et al. Shared 
constitutional risks for maternal vascular-related 
pregnancy complications and future cardiovascular 
disease. Hypertension. 2008;51:1034-41. 
27. Bushnell C, McCullough LD, Awad IA, et al. 
Guidelines for the prevention of stroke in women: a 
statement for healthcare professionals from the 
American Heart Association/American Stroke 
Association Stroke. 2014;45:1545-88.  
28. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based 
guidelines for the prevention of cardiovascular disease in 
women--2011 update: a guideline from the american heart 
association Circulation. 2011;123:1243-62.  
29. Williams D. Pregnancy: a stress test for life. Curr Opin 
Obstet Gynecol. 2003;15:465-71.  
30. Westerlund E, Brandt L, Hovatta O, Wallén H, Ekbom 
A, Henriksson P. Incidence of hypertension, stroke, 
coronary heart disease, and diabetes in women who 
have delivered after in vitro fertilization: a population-
based cohort study from Sweden. Fertil Steril. 
2014;102:1096-1102.  
31. Howell EP, Harris BS, Kuller JA, Acharya KS. 
Preconception Evaluation Before In Vitro 
Fertilization. Obstet Gynecol Surv. 2020;75:359-68.  
 
 
Citation: Cirillo M, Coccia ME, Fatini C. Lifestyle 
and Comorbidities: Do We Take Enough Care of 
Preconception Health in Assisted Reproduction? J 
Fam Reprod Health 2020; 14(3): 150-7. 
 
 
